Role signal
Principal Biostatistician is the largest imported role bucket with 9 matching rows.
LCA activity
Recent labor-condition rows help reveal roles, worksites, wages, and case statuses. LCA certification is not USCIS petition approval.
Imported LCA rows
62
Median wage
$143,250
Source period
FY2026 Q2
LCA query context
For searches like "Novartis Pharmaceuticals LCA", start with the official filing count, then compare role, worksite, wage, and status signals before opening individual rows.
Principal Biostatistician is the largest imported role bucket with 9 matching rows.
East Hanover, NJ is the largest imported worksite cluster with 61 matching rows.
Certified is the largest observed case-status bucket with 72 rows.
| Case | Status | Decision | Role | Worksite | Wage | Source |
|---|---|---|---|---|---|---|
| I-200-26083-724939 | Certified | Mar 31, 2026 | Clinical Trial Leader I | East Hanover, NJ | $141,398 | FY2026 Q2 |
| I-200-26083-725904 | Certified | Mar 31, 2026 | AD, Patient and Provider Analytics - CRM | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26083-724844 | Certified | Mar 31, 2026 | Principal Biostatistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26083-725059 | Certified | Mar 31, 2026 | Finance Manager | East Hanover, NJ | $73,195 | FY2026 Q2 |
| I-200-26083-725458 | Certified | Mar 31, 2026 | Associate Director, Patient & Provider Analytics | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26083-724794 | Certified | Mar 31, 2026 | Expert CMC Statistics | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26083-725980 | Certified | Mar 31, 2026 | Senior Principal Statistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26082-722422 | Certified | Mar 30, 2026 | Associate Clinical Development Medical Director | East Hanover, NJ | $116,730 | FY2026 Q2 |
| I-200-26082-722480 | Certified | Mar 30, 2026 | Principal Biostatistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26079-719490 | Certified | Mar 27, 2026 | Principal Biostatistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26079-719471 | Certified | Mar 27, 2026 | Principal Biostatistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26079-719544 | Certified | Mar 27, 2026 | Principal Biostatistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26079-719246 | Certified | Mar 27, 2026 | Study Leader | East Hanover, NJ | $141,398 | FY2026 Q2 |
| I-200-26079-719436 | Certified | Mar 27, 2026 | Associate Director, PSC Operations Insights | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26079-719296 | Certified | Mar 27, 2026 | Director, Product Strategy Counsel | East Hanover, NJ | $156,832 | FY2026 Q2 |
| I-200-26079-719371 | Certified | Mar 27, 2026 | AD, Integrated Field Execution Effectiveness - CE | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26078-714738 | Certified | Mar 26, 2026 | Principal Biostatistician | East Hanover, NJ | $112,965 | FY2026 Q2 |
| I-200-26078-714702 | Certified | Mar 26, 2026 | Director, Forecasting-CV | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26078-715666 | Certified | Mar 26, 2026 | Expert Science & Technology | East Hanover, NJ | $96,054 | FY2026 Q2 |
| I-200-26078-714721 | Certified | Mar 26, 2026 | Associate Expert Potency | East Hanover, NJ | $89,419 | FY2026 Q2 |
| I-200-26078-715164 | Certified | Mar 26, 2026 | Principal Biostatistician | Cambridge, MA | $89,731 | FY2026 Q2 |
| I-200-26077-713989 | Certified | Mar 25, 2026 | Director, Emerging Data Products - NS | East Hanover, NJ | $223,642 | FY2026 Q2 |
| I-200-26077-711495 | Certified | Mar 25, 2026 | Head of Strategy, US | East Hanover, NJ | $223,142 | FY2026 Q2 |
| I-200-26077-713980 | Certified | Mar 25, 2026 | Associate Director, Business Performance - CRM | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26077-713437 | Certified | Mar 25, 2026 | Operational Health Project Manager | East Hanover, NJ | $129,709 | FY2026 Q2 |
| I-200-26077-713499 | Certified | Mar 25, 2026 | FDP Associate | East Hanover, NJ | $112,778 | FY2026 Q2 |
| I-200-26069-692117 | Certified | Mar 17, 2026 | Technology Product Director | East Hanover, NJ | $223,642 | FY2026 Q2 |
| I-200-26068-688719 | Certified | Mar 16, 2026 | Director, Integrated Field Targeting and NBA - CE | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26051-655231 | Certified | Feb 27, 2026 | Senior Product Manager - Novartis Patient Support | East Hanover, NJ | $126,818 | FY2026 Q2 |
| I-200-26041-632070 | Certified | Feb 18, 2026 | Associate Director, Monitoring and Standards | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-26006-536924 | Certified | Jan 13, 2026 | Senior Principal Product Service Manager | East Hanover, NJ | $126,818 | FY2026 Q2 |
| I-200-26006-536830 | Certified | Jan 13, 2026 | Global Regulatory Submission Manager | East Hanover, NJ | $141,190 | FY2026 Q2 |
| I-200-25353-498907 | Certified | Dec 29, 2025 | Director, Resource Optimization Commercial | East Hanover, NJ | $223,142 | FY2026 Q1 |
| I-200-25353-498907 | Certified | Dec 29, 2025 | Director, Resource Optimization Commercial | East Hanover, NJ | $223,142 | FY2026 Q2 |
| I-200-25344-473590 | Certified | Dec 17, 2025 | Director, Resource Optimization Commercial | East Hanover, NJ | $223,142 | FY2026 Q2 |
| I-200-25344-473826 | Certified | Dec 17, 2025 | Director, AI Use Case Lead | East Hanover, NJ | $185,723 | FY2026 Q1 |
| I-200-25344-473826 | Certified | Dec 17, 2025 | Director, AI Use Case Lead | East Hanover, NJ | $185,723 | FY2026 Q2 |
| I-200-25344-473590 | Certified | Dec 17, 2025 | Director, Resource Optimization Commercial | East Hanover, NJ | $223,142 | FY2026 Q1 |
| I-200-25329-438434 | Certified | Dec 3, 2025 | Director - Decision Science, Immunology Product Lead | East Hanover, NJ | $138,466 | FY2026 Q1 |
| I-200-25329-438434 | Certified | Dec 3, 2025 | Director - Decision Science, Immunology Product Lead | East Hanover, NJ | $138,466 | FY2026 Q2 |
| I-200-25325-430549 | Certified | Dec 1, 2025 | BPO Order Management & Finance, C&G | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-25325-430549 | Certified | Dec 1, 2025 | BPO Order Management & Finance, C&G | East Hanover, NJ | $169,541 | FY2026 Q1 |
| I-200-25323-423451 | Certified | Nov 26, 2025 | Product Strategy Lead, Stroke Prevention in A-Fib | East Hanover, NJ | $199,410 | FY2026 Q1 |
| I-200-25323-423451 | Certified | Nov 26, 2025 | Product Strategy Lead, Stroke Prevention in A-Fib | East Hanover, NJ | $199,410 | FY2026 Q2 |
| I-200-25316-402734 | Certified | Nov 19, 2025 | Expert Science & Technology | Cambridge, MA | $122,450 | FY2026 Q1 |
| I-200-25316-402734 | Certified | Nov 19, 2025 | Expert Science & Technology | Cambridge, MA | $122,450 | FY2026 Q2 |
| I-200-25315-399038 | Certified | Nov 18, 2025 | Senior Principal Biostatistician | Cambridge, MA | $127,858 | FY2026 Q2 |
| I-200-25315-399038 | Certified | Nov 18, 2025 | Senior Principal Biostatistician | Cambridge, MA | $127,858 | FY2026 Q1 |
| I-200-25311-387470 | Certified | Nov 17, 2025 | Associate Director, Integrated Field Targeting & NBA | East Hanover, NJ | $169,541 | FY2026 Q1 |
| I-200-25311-387470 | Certified | Nov 17, 2025 | Associate Director, Integrated Field Targeting & NBA | East Hanover, NJ | $169,541 | FY2026 Q2 |
| I-200-25307-364234 | Certified | Nov 14, 2025 | Associate Director, Biostatistics | East Hanover, NJ | $175,781 | FY2026 Q1 |
| I-200-25308-368990 | Certified | Nov 14, 2025 | ED, Portfolio & Early Pipeline Strategy | East Hanover, NJ | $199,410 | FY2026 Q1 |
| I-200-25307-364234 | Certified | Nov 14, 2025 | Associate Director, Biostatistics | East Hanover, NJ | $175,781 | FY2026 Q2 |
| I-200-25307-366373 | Certified | Nov 14, 2025 | AD, Integrated Field Deployment & GTM Analytics | East Hanover, NJ | $139,506 | FY2026 Q1 |
| I-200-25308-368990 | Certified | Nov 14, 2025 | ED, Portfolio & Early Pipeline Strategy | East Hanover, NJ | $199,410 | FY2026 Q2 |
| I-200-25307-366373 | Certified | Nov 14, 2025 | AD, Integrated Field Deployment & GTM Analytics | East Hanover, NJ | $139,506 | FY2026 Q2 |
| I-200-25304-353043 | Certified | Nov 7, 2025 | Expert Science & Technology | Durham, NC | $112,757 | FY2026 Q1 |
| I-200-25304-353043 | Certified | Nov 7, 2025 | Expert Science & Technology | Durham, NC | $112,757 | FY2026 Q2 |
| I-200-25272-340819 | Certified | Nov 6, 2025 | Principal Biostatistician | Cambridge, MA | $127,858 | FY2026 Q2 |
| I-200-25272-343198 | Certified | Nov 6, 2025 | Manager, HCP Education Delivery | East Hanover, NJ | $143,250 | FY2026 Q1 |
| I-200-25272-343198 | Certified | Nov 6, 2025 | Manager, HCP Education Delivery | East Hanover, NJ | $143,250 | FY2026 Q2 |
| I-200-25272-340819 | Certified | Nov 6, 2025 | Principal Biostatistician | Cambridge, MA | $127,858 | FY2026 Q1 |
Primary source
LCA rows for Novartis Pharmaceuticals are imported from DOL OFLC LCA Disclosure Data, the official US Department of Labor disclosure dataset. See About data for source caveats and Source status for import freshness.
DOL OFLC performance pageLast verified: .
FAQ
The Novartis Pharmaceuticals LCA page summarizes imported Department of Labor labor-condition rows for this normalized employer, including roles, worksites, wages, case statuses, and source periods.
No. LCA certification is an official DOL labor-condition filing signal, but USCIS decides H-1B petitions separately. Use the page as employer research context, not as an approval record.
Searches like "Novartis Pharmaceuticals H-1B" or "Novartis Pharmaceuticals H-1B sponsor" are best read against this LCA filing activity, which reflects historical labor-condition signals at Novartis Pharmaceuticals. It is not a promise of future sponsorship or an indicator of any individual case outcome.
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.